Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
Rhea-AI Summary
Haemonetics (NYSE: HAE) announced its second quarter fiscal 2026 financial results for the period ended September 27, 2025 are available on the company's Investor Relations website.
The company will host a live conference call and webcast with investors and analysts at 8:00 a.m. ET on November 6, 2025. A replay will be available beginning at 11:00 a.m. ET on November 6, 2025 and will remain accessible for one year via the webcast link. Earnings materials posted include the Second Quarter Fiscal 2026 Earnings Release and a Supplemental Earnings Presentation.
Positive
- None.
Negative
- None.
News Market Reaction 89 Alerts
On the day this news was published, HAE gained 32.31%, reflecting a significant positive market reaction. Argus tracked a peak move of +29.2% during that session. Our momentum scanner triggered 89 alerts that day, indicating high trading interest and price volatility. This price movement added approximately $840M to the company's valuation, bringing the market cap to $3.44B at that time. Trading volume was exceptionally heavy at 6.3x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
Financial release and supplemental presentation accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 6, 2025.
Conference Call and Webcast Information:
- Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
- Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on November 6, 2025 and will remain accessible for one year via the webcast link above.
Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
- Second Quarter Fiscal 2026 Earnings Release
- Second Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
|
Investor Contacts: |
|
|
Olga Guyette, Vice President-Investor Relations & Treasury |
David Trenk, Manager-Investor Relations |
|
(781) 356-9763 |
(203) 733-4987 |
|
|
|
|
Media Contact: |
|
|
Josh Gitelson, Sr. Director-Global Communications |
|
|
(781) 356-9776 |
|
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-corporation-announces-second-quarter-fiscal-2026-financial-results-available-on-investor-relations-website-302606803.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) discuss Q2 fiscal 2026 results?
Where can I find Haemonetics (HAE) Q2 fiscal 2026 earnings release and presentation?
How can investors join the Haemonetics (HAE) conference call on November 6, 2025?
Will there be a replay of the Haemonetics (HAE) Q2 fiscal 2026 webcast?
What time period does Haemonetics' Q2 fiscal 2026 cover for the November 6, 2025 results?
